| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |